All Stories

  1. The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

    Article • Reumatismo, July 2025, PAGEPress Publications

    Dr Matteo Piga

  2. Lupus serology: off target but still relevant to the treat-to-target strategy in systemic lupus erythematosus

    Article • Rheumatology, June 2025, Oxford University Press (OUP)

    Dr Matteo Piga

  3. Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial

    Article • Annals of the Rheumatic Diseases, March 2025, Elsevier

    Dr Matteo Piga

  4. VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management

    Article • Annals of Hematology, January 2025, Springer Science + Business Media

    Dr Matteo Piga

  5. Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study

    Article • Lupus Science & Medicine, January 2025, BMJ

    Dr Matteo Piga

  6. Levels of physical activity in a large international cohort of patients with systemic lupus erythematosus

    Article • Lupus Science & Medicine, January 2025, BMJ

    Dr Matteo Piga

  7. Sex Differences in Cardiovascular Risk Profiles of Patients with Rheumatoid Arthritis: Results from an Italian Multicentre Cohort

    Article • Journal of Clinical Medicine, November 2024, MDPI AG

    Dr Matteo Piga

  8. Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study

    Article • The Journal of Rheumatology, July 2024, The Journal of Rheumatology

    Dr Matteo Piga

  9. Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature Review

    Article • The Journal of Rheumatology, February 2024, The Journal of Rheumatology

    Dr Matteo Piga

  10. Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes

    Article • Healthcare, January 2024, MDPI AG

    Dr Matteo Piga

  11. Assessment and personalised advice for fatigue in systemic lupus erythematosus using an innovative digital tool: the Lupus Expert system for the Assessment of Fatigue (LEAF) study

    Article • RMD Open, December 2023, BMJ

    Dr Matteo Piga

  12. Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease

    Article • Best Practice & Research Clinical Rheumatology, December 2023, Elsevier

    Dr Matteo Piga

  13. Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study

    Article • Lupus Science & Medicine, November 2023, BMJ

    Dr Matteo Piga

  14. The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort

    Article • Journal of Clinical Medicine, September 2023, MDPI AG

    Dr Matteo Piga

  15. Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS)

    Article • Journal of Personalized Medicine, April 2023, MDPI AG

    Dr Matteo Piga

  16. Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group

    Article • Journal of Clinical Medicine, March 2023, MDPI AG

    Dr Matteo Piga

  17. Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium

    Article • Journal of Clinical Medicine, October 2022, MDPI AG

    Dr Matteo Piga

  18. Physician global assessment in systemic lupus erythematosus: can we rely on its reliability?

    Article • Annals of the Rheumatic Diseases, May 2022, Elsevier

    Dr Matteo Piga

  19. Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity

    Article • Rheumatology, April 2022, Oxford University Press (OUP)

    Dr Matteo Piga

  20. Whole-Body MRI in Rheumatology: Major Advances and Future Perspectives

    Article • Diagnostics, September 2021, MDPI AG

    Dr Matteo Piga

  21. Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis

    Article • Clinical Rheumatology, August 2021, Springer Science + Business Media

    Dr Matteo Piga

  22. Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic

    Article • Rheumatology, August 2021, Oxford University Press (OUP)

    Dr Matteo Piga

  23. Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?

    Article • Current Pharmaceutical Design, June 2021, Bentham Science Publishers

    Dr Panagiotis Paliogiannis, Dr Salvatore Sotgia, Dr Matteo Piga, Arduino Mangoni

  24. Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs

    Article • Medicine, April 2021, Wolters Kluwer Health

    Dr Matteo Piga

  25. Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?

    Article • Annals of the Rheumatic Diseases, March 2021, Elsevier

    Dr Matteo Piga

  26. Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic Arthritis

    Article • Open Access Rheumatology Research and Reviews, March 2021, Taylor & Francis

    Dr Matteo Piga

  27. Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review

    Article • BioDrugs, February 2021, Springer Science + Business Media

    Dr Matteo Piga

  28. The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?

    Article • Journal of Clinical Medicine, January 2021, MDPI AG

    Dr Matteo Piga

  29. Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud’s arthropathy and a distinctive MRI pattern

    Article • Rheumatology, January 2021, Oxford University Press (OUP)

    Dr Matteo Piga

  30. Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties

    Article • Rheumatology, August 2020, Oxford University Press (OUP)

    Dr Matteo Piga

  31. Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI)

    Article • RMD Open, July 2020, BMJ

    Dr Matteo Piga

  32. Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age

    Article • Current Pharmaceutical Design, December 2019, Bentham Science Publishers

    Dr Matteo Piga, Dr Salvatore Sotgia, Stefania Bassu

  33. Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort

    Article • Rheumatology, December 2019, Oxford University Press (OUP)

    Dr Matteo Piga

  34. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

    Article • Journal of Clinical Medicine, November 2019, MDPI AG

    Dr Matteo Piga

  35. Treatment target in newly diagnosed Systemic Lupus Erythematosus

    Article • Arthritis Care & Research, October 2019, Wiley

    Dr Matteo Piga

  36. Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet’s Syndrome

    Article • Open Access Rheumatology Research and Reviews, October 2019, Taylor & Francis

    Dr Alberto Floris, Dr Matteo Piga

  37. The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia

    Article • Rheumatology, June 2019, Oxford University Press (OUP)

    Dr Matteo Piga, Professor Rosa Sorrentino

  38. Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response

    Article • Frontiers in Pharmacology, April 2019, Frontiers

    Dr Matteo Piga

  39. Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning–Based Tissue Characterization

    Article • Current Atherosclerosis Reports, January 2019, Springer Science + Business Media

    Dr Matteo Piga

  40. How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria

    Article • Arthritis & Rheumatology, November 2018, Wiley

    Dr Matteo Piga, Dr. Zahi Touma

  41. AIF-1 gene does not confer susceptibility to Behçet’s disease: Analysis of extended haplotypes in Sardinian population

    Article • PLOS One, September 2018, PLOS

    Dr Matteo Piga, Professor Rosa Sorrentino

  42. Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis

    Article • RMD Open, July 2018, BMJ

    Dr Matteo Piga, Professor Rosa Sorrentino

  43. Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol

    Article • BMJ Open, July 2018, BMJ

    Dr Matteo Piga

  44. Polymyalgia rheumatica: an autoinflammatory disorder?

    Article • RMD Open, June 2018, BMJ

    Dr Matteo Piga

  45. Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset

    Article • Lupus, May 2018, SAGE Publications

    Dr Matteo Piga, Gian Domenico Sebastiani

  46. Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study

    Article • Mediators of Inflammation, January 2018, Hindawi Publishing Corporation

    Dr Matteo Piga, Gian Luca Erre, Barbara Tolusso, Arduino Mangoni

  47. Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus

    Article • Mediators of Inflammation, January 2018, Hindawi Publishing Corporation

    Dr Matteo Piga, Gian Luca Erre, Dr Alberto Floris, Arduino Mangoni

  48. Atherosclerosis and Autoimmunity

    Article • Mediators of Inflammation, January 2018, Hindawi Publishing Corporation

    Dr Matteo Piga

  49. Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus

    Article • November 2017, Springer Science + Business Media

    Dr Matteo Piga

  50. Rituximab is a valid alternative to standard of care in severe inflammatory neuropsychiatric lupus.

    Article • Open Access Rheumatology Research and Reviews, September 2017, Dove Medical Press

    Dr Matteo Piga, Dr Alberto Floris

  51. Telemedicine for patients with rheumatic diseases: Systematic review and proposal for research agenda

    Article • Seminars in Arthritis and Rheumatism, August 2017, Elsevier

    Dr Matteo Piga

  52. Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus

    Article • Lupus, June 2017, SAGE Publications

    Dr Matteo Piga

  53. Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study

    Article • Frontiers in Pharmacology, June 2017, Frontiers

    Dr Matteo Piga

  54. Overexpression of the Cytokine BAFF and Autoimmunity Risk

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2017, New England Journal of Medicine (NEJM/MMS)

    Dr Matteo Piga

  55. Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis

    Article • Autoimmunity Reviews, March 2017, Elsevier

    Dr Matteo Piga

  56. Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence

    Article • Mediators of Inflammation, January 2017, Hindawi Publishing Corporation

    Gian Luca Erre, Dr Matteo Piga, Arduino Mangoni, Dr Salvatore Sotgia

  57. Pachydermopériostose, un cas d’épanchement articulaire volumineux avec atteinte polyarticulaire imitant l’arthrite juvénile idiopathique

    Article • Revue du Rhumatisme, December 2016, Elsevier

    Dr Matteo Piga

  58. Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: comparison with computed tomography

    Article • October 2016, Springer Science + Business Media

    Dr Matteo Piga, Professor Luca Saba

  59. Predictors of musculoskeletal flares and Jaccoud׳s arthropathy in patients with systemic lupus erythematosus: A 5-year prospective study

    Article • Seminars in Arthritis and Rheumatism, October 2016, Elsevier

    Dr Matteo Piga

  60. Hand tele-rehabilitation system

    Article • Journal of Telemedicine and Telecare, July 2016, SAGE Publications

    Dr Danilo Pani, Dr Matteo Piga, luigi raffo

  61. Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review

    Article • Autoimmunity Reviews, July 2016, Elsevier

    Dr Matteo Piga

  62. Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: results from the observational study STARTER of the Italian Society for Rheumatology

    Article • Rheumatology, June 2016, Oxford University Press (OUP)

    Dr Matteo Piga

  63. Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report

    Article • Joint Bone Spine, January 2016, Elsevier

    Dr Matteo Piga

  64. The Ankylosing Spondylitis-Associated HLA-B*2705 Presents a B*0702-Restricted EBV Epitope and Sustains the Clonal Amplification of Cytotoxic T Cells in Patients

    Article • World Journal of Surgery, January 2016, The Feinstein Institute for Medical Research (North Shore LIJ Research Institute)

    Dr Matteo Piga, Professor Rosa Sorrentino

  65. The Difficult Task of Assessing Psoriatic Arthritis

    Article • The Journal of Rheumatology, December 2015, The Journal of Rheumatology

    Dr Matteo Piga

  66. New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol

    Article • Journal of Rheumatology Supplement, November 2015, The Journal of Rheumatology

    Dr Matteo Piga

  67. Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)

    Article • ImmunoTargets and Therapy, October 2015, Dove Medical Press

    Dr Alberto Floris, Dr Matteo Piga

  68. Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012

    Article • Rheumatology International, July 2015, Springer Science + Business Media

    Dr Matteo Piga

  69. Epidemiology of systemic lupus erythematosus in Sardinia.

    Article • Lupus, July 2015, SAGE Publications

    Dr Matteo Piga

  70. Twenty-year brain magnetic resonance imaging follow-up study in Systemic Lupus Erythematosus: Factors associated with accrual of damage and central nervous system involvement

    Article • Autoimmunity Reviews, June 2015, Elsevier

    Dr Matteo Piga

  71. Early Lupus Project – A multicentre Italian study on systemic lupus erythematosus of recent onset

    Article • Lupus, May 2015, SAGE Publications

    Dr Matteo Piga

  72. Killer-Cell Immunoglobulin-Like Receptors (KIR) and HLA-Class I Heavy Chains in Ankylosing Spondylitis

    Article • Drug Development Research, November 2014, Wiley

    Dr Matteo Piga

  73. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus

    Article • Rheumatology, October 2014, Oxford University Press (OUP)

    Dr Matteo Piga

  74. Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort

    Article • Autoimmunity Reviews, August 2014, Elsevier

    Dr Matteo Piga

  75. Clinical potential of apremilast in the treatment of psoriatic arthritis

    Article • ImmunoTargets and Therapy, June 2014, Taylor & Francis

    Dr Matteo Piga

  76. Telemedicine Applied to Kinesiotherapy for Hand Dysfunction in Patients with Systemic Sclerosis and Rheumatoid Arthritis: Recovery of Movement and Telemonitoring Technology

    Article • The Journal of Rheumatology, June 2014, The Journal of Rheumatology

    Dr Matteo Piga, luigi raffo

  77. A Device for Local or Remote Monitoring of Hand Rehabilitation Sessions for Rheumatic Patients

    Article • IEEE Journal of Translational Engineering in Health and Medicine, January 2014, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Matteo Piga, luigi raffo

  78. Section 2: Spondyloarthritis

    Article • Clinical Drug Investigation, August 2013, Springer Science + Business Media

    Dr Matteo Piga

  79. The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09

    Article • Rheumatology, June 2013, Oxford University Press (OUP)

    Dr Matteo Piga

  80. Rituximab treatment for ‘rhupus syndrome’: clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study

    Article • Lupus, April 2013, SAGE Publications

    Dr Matteo Piga

  81. An Integrated Portable Device for the Hand Functional Assessment in the Clinical Practice

    Article • January 2013, Springer Science + Business Media

    Dr Matteo Piga, luigi raffo

  82. Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests

    Article • Arthritis Research & Therapy, January 2013, Springer Science + Business Media

    Dr Matteo Piga

  83. Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients

    Article • Rheumatology, September 2012, Oxford University Press (OUP)

    Dr Matteo Piga

  84. Myocardial Positron Emission Tomography/Computed Tomography Scan Revealing Right Coronary Artery Involvement in Large Vessel Vasculitis

    Article • The Journal of Rheumatology, August 2012, The Journal of Rheumatology

    Dr Matteo Piga

  85. Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time

    Article • Scandinavian Journal of Rheumatology, February 2012, Taylor & Francis

    Dr Matteo Piga, Professor Rosa Sorrentino

  86. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients

    Article • Rheumatology, November 2011, Oxford University Press (OUP)

    Dr Matteo Piga

  87. Managing CNS involvement in systemic lupus erythematosus

    Article • International Journal of Clinical Rheumatology, October 2011, OMICS Publishing Group

    Dr Matteo Piga

  88. Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum?

    Article • Lupus, September 2011, SAGE Publications

    Dr Matteo Piga

  89. GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS

    Article • Reumatismo, September 2011, PAGEPress Publications

    Dr Matteo Piga

  90. Post-Streptococcal Reactive Arthritis Associated With Group G Streptococcal Pharyngitis

    Article • JCR Journal of Clinical Rheumatology, December 2010, Wolters Kluwer Health

    Dr Matteo Piga

  91. Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region

    Article • Rheumatology, November 2010, Oxford University Press (OUP)

    Dr Matteo Piga

  92. Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al

    Article • Scandinavian Journal of Rheumatology, November 2010, Taylor & Francis

    Dr Matteo Piga

  93. Multiple Septic Bursitis and Spontaneous Achilles Tendon Tear in Systemic Lupus Erythematosus

    Article • The Journal of Rheumatology, November 2010, The Journal of Rheumatology

    Dr Matteo Piga

  94. Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study

    Article • Lupus, April 2010, SAGE Publications

    Dr Matteo Piga

  95. Familial chilblain and late contractural arachnodactyly: A novel association?

    Article • Joint Bone Spine, March 2009, Elsevier

    Dr Matteo Piga

  96. Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission

    Article • Clinical Rheumatology, September 2008, Springer Science + Business Media

    Dr Matteo Piga